Axovant Sciences to pick up $55 mln from Hercules Capital
Hercules Capital has agreed to provide $55 million in funding to Axovant Sciences. Based in Bermuda and New York City, Axovant is a biopharmaceutical company focused on treating dementia.
3 February 2017•1 min read
